STOCK TITAN

[Form 3] Baxter International Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Andrew P. Hider filed a Form 3 for Baxter International Inc. (BAX) reporting his relationship to the issuer as Director and President and CEO. The Form 3 reports 0 shares of Baxter common stock beneficially owned as of the 08/19/2025 event date. The filing was signed by attorney in-fact Ellen K. Bradford on 08/25/2025.

Andrew P. Hider ha presentato un Modulo 3 per Baxter International Inc. (BAX), dichiarando il suo rapporto con l'emittente come Director e President and CEO. Il Modulo 3 indica la detenzione beneficiaria di 0 azioni ordinarie di Baxter alla data dell'evento 19/08/2025. La comunicazione è stata firmata dall'avvocato delegato Ellen K. Bradford il 25/08/2025.

Andrew P. Hider presentó un Formulario 3 para Baxter International Inc. (BAX), indicando su relación con el emisor como Director y President and CEO. El Formulario 3 informa que posee de forma beneficiaria 0 acciones ordinarias de Baxter con fecha del evento 19/08/2025. La presentación fue firmada por la apoderada legal Ellen K. Bradford el 25/08/2025.

Andrew P. Hider는 Baxter International Inc. (BAX)에 대해 양식 3을 제출했으며, 발행인과의 관계를 DirectorPresident and CEO로 보고했습니다. 이 양식 3은 사건일자 2025년 8월 19일 기준으로 Baxter 보통주를 수익적으로 보유한 주식이 0주임을 보고합니다. 서류는 2025년 8월 25일 법정대리인 Ellen K. Bradford가 서명했습니다.

Andrew P. Hider a déposé un Formulaire 3 pour Baxter International Inc. (BAX), déclarant sa relation avec l'émetteur comme Director et President and CEO. Le Formulaire 3 signale la détention bénéficiaire de 0 actions ordinaires de Baxter à la date de l'événement du 19/08/2025. Le document a été signé par la mandataire juridique Ellen K. Bradford le 25/08/2025.

Andrew P. Hider reichte ein Formular 3 für Baxter International Inc. (BAX) ein und bezeichnete seine Beziehung zum Emittenten als Director und President and CEO. Im Formular 3 wird angegeben, dass er zum Stichtag des Ereignisses am 19.08.2025 wirtschaftlich 0 Aktien der Stammaktien von Baxter besitzt. Die Einreichung wurde am 25.08.2025 von der bevollmächtigten Anwältin Ellen K. Bradford unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Company insider listed as Director and President/CEO reported no direct beneficial ownership on initial Form 3.

The Form 3 notifies investors that Andrew P. Hider holds roles as both a director and the company’s President and CEO while reporting zero shares of Baxter common stock. For governance monitoring, this is a routine initial disclosure that establishes public record of the officer/director relationship and current equity ownership. No equity-based derivative positions or indirect holdings are reported, and the filing contains no additional explanatory remarks.

TL;DR: Initial insider disclosure shows no direct equity stake; this is informational but not material on its own.

From a market-impact perspective, the filing simply documents an insider relationship and a zero-share position as of 08/19/2025. There are no reported options, warrants, convertible instruments, or indirect ownership claims on the Form 3. This disclosure should be treated as routine compliance with Section 16 reporting rather than a material corporate event.

Andrew P. Hider ha presentato un Modulo 3 per Baxter International Inc. (BAX), dichiarando il suo rapporto con l'emittente come Director e President and CEO. Il Modulo 3 indica la detenzione beneficiaria di 0 azioni ordinarie di Baxter alla data dell'evento 19/08/2025. La comunicazione è stata firmata dall'avvocato delegato Ellen K. Bradford il 25/08/2025.

Andrew P. Hider presentó un Formulario 3 para Baxter International Inc. (BAX), indicando su relación con el emisor como Director y President and CEO. El Formulario 3 informa que posee de forma beneficiaria 0 acciones ordinarias de Baxter con fecha del evento 19/08/2025. La presentación fue firmada por la apoderada legal Ellen K. Bradford el 25/08/2025.

Andrew P. Hider는 Baxter International Inc. (BAX)에 대해 양식 3을 제출했으며, 발행인과의 관계를 DirectorPresident and CEO로 보고했습니다. 이 양식 3은 사건일자 2025년 8월 19일 기준으로 Baxter 보통주를 수익적으로 보유한 주식이 0주임을 보고합니다. 서류는 2025년 8월 25일 법정대리인 Ellen K. Bradford가 서명했습니다.

Andrew P. Hider a déposé un Formulaire 3 pour Baxter International Inc. (BAX), déclarant sa relation avec l'émetteur comme Director et President and CEO. Le Formulaire 3 signale la détention bénéficiaire de 0 actions ordinaires de Baxter à la date de l'événement du 19/08/2025. Le document a été signé par la mandataire juridique Ellen K. Bradford le 25/08/2025.

Andrew P. Hider reichte ein Formular 3 für Baxter International Inc. (BAX) ein und bezeichnete seine Beziehung zum Emittenten als Director und President and CEO. Im Formular 3 wird angegeben, dass er zum Stichtag des Ereignisses am 19.08.2025 wirtschaftlich 0 Aktien der Stammaktien von Baxter besitzt. Die Einreichung wurde am 25.08.2025 von der bevollmächtigten Anwältin Ellen K. Bradford unterzeichnet.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Hider Andrew P.

(Last) (First) (Middle)
ONE BAXTER PARKWAY

(Street)
DEERFIELD IL 60015

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/19/2025
3. Issuer Name and Ticker or Trading Symbol
BAXTER INTERNATIONAL INC [ BAX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $1 par value 0 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Ellen K. Bradford, as attorney in-fact for Andrew P. Hider 08/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Andrew P. Hider report on the Form 3 for BAX?

The filing reports Andrew P. Hider as a Director and President and CEO of Baxter and shows 0 shares of common stock beneficially owned.

What is the event date and filing date on the Form 3 for BAX?

The event requiring the statement is dated 08/19/2025 and the Form 3 was signed by attorney in-fact on 08/25/2025.

Does the Form 3 show any derivative securities or indirect ownership for Andrew P. Hider?

No. Table II for derivative securities is empty and the Form 3 reports no indirect beneficial ownership.

Who signed the Form 3 on behalf of Andrew P. Hider?

The Form 3 was signed by Ellen K. Bradford, acting as attorney in-fact for Andrew P. Hider.

Is the Form 3 considered a material disclosure for investors in BAX?

The Form 3 is a routine Section 16 initial ownership disclosure; it documents roles and current ownership but contains no material transaction or holdings.
Baxter Intl Inc

NYSE:BAX

BAX Rankings

BAX Latest News

BAX Latest SEC Filings

BAX Stock Data

12.61B
511.70M
0.28%
99.17%
3.72%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
DEERFIELD